Medication Assisted Treatment


The District Recovery Community is proud to announce that we will launch our Medication Assisted Treatment (M.A.T.)


TDRC and its respective leadership have completed a year of research and development and we’re finally prepared to effectively launch our M.A.T. track and provide supportive aid to a wider range of clinical needs.

Our purpose is pure and simple in its nature; To provide a harm reduction service and introduce a Long-Term solution to a new demographic.

Our mission is to provide a long-term, safe-haven for clients in need of extended medication management & assistance. Ultimately eliminating the unfortunate amount of ineffective re-cycling treatment episodes.

Our M.A.T. track will be limited to male clients at first and pre-approval will be determined by our Medical Director after an extensive & customized pre-intake assessment.

The clients participating in this track will be seen weekly by our Medical Director for assessment and appropriate administration of their medications.

Again, abstinence will ALWAYS be the primary goal, how long until this goal is reached will be decided by our clients and Medical Director.

The Administration of their medication will always be in conjunction with extensive therapeutic services provided by their out-patient program, social support groups, a well-established vocation/employment program, experiential & adventure therapies as well as individual sessions with professional clinicians.

For more information on the beneficial properties of Buprenorphine and medications alike,we encourage you to read articles produced by the Substance Abuse Mental Health Services Administration;

Harm reduction and Success measurements:

About MAT Treatment

According to the National Safety Council, the odds of dying from an accidental opioid overdose are greater than those of dying in a car accident.   The CDC reports 70,237 drug overdose deaths occurred in the United States in 2017.


Medication Assisted Treatment (MAT) is the use of FDA-approved medications in conjunction with other counseling and behavioral therapies. This treatment option is overseen by a medical doctor who has received the additional necessary training to treat substance use disorder with the assistance of conjunctive medication.



bicycles on huntington beach bicyclist


A common misconception associated with MAT is that it substitutes one drug for another, instead these medications relieve the withdrawal symptoms and psychological cravings that cause chemical imbalances in the body. This provides stability for the client so that they can begin the necessary clinical work they need in order to achieve long term recovery.


Buprenorphine, approved for use in 2002 by the FDA, represents the latest advance in MAT. Utilization of Buprenorphine in combination with other treatment modalities provide a whole patient approach to opioid dependency. Buprenorphine is a partial opioid agonist, it satisfies the body’s craving for opiate therefore eliminating withdrawals. It does not produce the same level of euphoria. Buprenorphine has a “ceiling effect” which reduces the potential for misuse.

We Provide:

– Safe and secured medication storage

– A finished medication management process

– A professional, medical grade disposal process

– One-on-ones with Therapists

– One-on-ones with Case Managers

– Medication management groups

– Individual sessions with your doctor

– Vocational development groups

Male psychologist making notes during psychological therapy

Check Program Availability